UK markets open in 5 hours 52 minutes

Elanco Animal Health Incorporated (ELAN)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
31.18+0.77 (+2.53%)
At close: 4:00PM EDT

31.18 0.00 (0.00%)
After hours: 4:41PM EDT

Currency in USD

Valuation measures

Market cap (intra-day) 514.71B
Enterprise value 312.9B
Trailing P/E N/A
Forward P/E 129.70
PEG ratio (5-yr expected) 17.09
Price/sales (ttm)5.25
Price/book (mrq)1.87
Enterprise value/revenue 34.60
Enterprise value/EBITDA 624.90

Trading information

Stock price history

Beta (5Y monthly) 1.04
52-week change 315.63%
S&P500 52-week change 314.13%
52-week high 334.09
52-week low 315.17
50-day moving average 328.86
200-day moving average 324.57

Share statistics

Avg vol (3-month) 34.84M
Avg vol (10-day) 34.38M
Shares outstanding 5471.85M
Float 313.1M
% held by insiders 10.30%
% held by institutions 198.18%
Shares short (29 Sep 2020) 426.26M
Short ratio (29 Sep 2020) 46.57
Short % of float (29 Sep 2020) 46.11%
Short % of shares outstanding (29 Sep 2020) 45.57%
Shares short (prior month 30 Aug 2020) 421.44M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2019
Most-recent quarter (mrq)29 Jun 2020

Profitability

Profit margin -3.63%
Operating margin (ttm)7.64%

Management effectiveness

Return on assets (ttm)1.43%
Return on equity (ttm)-1.71%

Income statement

Revenue (ttm)2.8B
Revenue per share (ttm)7.18
Quarterly revenue growth (yoy)-25.00%
Gross profit (ttm)1.6B
EBITDA 518.2M
Net income avi to common (ttm)-101.8M
Diluted EPS (ttm)-0.26
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)1.39B
Total cash per share (mrq)3.49
Total debt (mrq)2.16B
Total debt/equity (mrq)32.49
Current ratio (mrq)3.82
Book value per share (mrq)16.68

Cash flow statement

Operating cash flow (ttm)329.5M
Levered free cash flow (ttm)554.32M